Change of guard at Avenue Supermarts: Noronha steps down, Unilever’s Asawa to be CMD

One of India’s richest CEOs Neville Noronha, who was with Avenue Supermarts for over two decades, has decided to end his tenure with the company. On Saturday, Avenue Supermarts, which runs the DMart chain of stores, said Noronha, 49, will not renew his candidature after his current term ends in January 2026.

Unilever’s Ansul Asawa, an IIT-IIM alumnus, will take over as MD & CEO of the company from February next year. Avenue Supermarts said Asawa will be CEO-designate from March 15, 2025, to ensure a smooth transition. Noronha will aid in the transition process over the next one year, the company said.

“After more than two decades of leadership and a glorious tenure at the helm of the business, Neville has chosen not to extend his contract. The board of directors honours his decision and expresses profound gratitude for his extraordinary contribution to the company,” Avenue Supermarts said in a statement on Saturday.

Also Read Fortis Healthcare appoints Leo Puri as Chairman of the Board Year-Ender 2024: Transformation in education; insights and trends to shape 2025 Slew of laws likely in 2025 to fix insolvency Tech landscape: AI regulation, chip push to take centre stage

Noronha has a 1.95% stake in the company at the end of the September 2024 quarter. This is worth Rs 4,676 crore at the end of Friday’s closing price on the BSE. Neville joined DMart in January 2004 and has led the company from its early years to its current position as one of the largest supermarket chains in the country. Avenue Supermarts said that Noronha’s strategy was focused on competent execution articulated in simple and precise terms, which was easy to understand across levels. Under his leadership, DMart reached significant milestones, including surpassing the Rs 50,000 crore annual turnover mark and growing from five stores, when Noronha joined the company, to 387 stores now.

Anshul Asawa, an IIT Roorkee and IIM Lucknow alumnus, will be joining DMart after a 30-year long stint at Unilever where he had leadership roles overseeing the growth of product categories and developing impactful functions in India, Asia, and Europe. He currently serves as country head of Unilever in Thailand and general manager for the home care business unit in Greater Asia.

DMart Q3 net up 5%;  » Read More

Related Articles

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain

Range bound session: Nifty ends above 23,600, Sensex holds 78,000 led by Adani Ports, Infosys

The stock markets faced a downturn on Thursday, with major indices closing in the red. The BSE Sensex dropped by 213.12 points or 0.27%, ending the day at 78,058.16, while the NSE Nifty 50 saw a decline of 70.15 points, down by 0.3%, and closed at 23,626.15. The Nifty Bank index also ended the day

IT stocks stable as Cognizant raises annual and quarterly revenue guidance

Shares of Indian IT companies are in the spotlight today after the Nasdaq-listed IT services major Cognizant Technology Solutions, reported its Q4 results that exceeded Wall Street expectations. The Nifty IT Index as well as individual tech counters like Infosys, Wipro, Tech Mahindra and HCL Tech are all in the green even as the markets